Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
Completed
National Cancer Institute (NCI)
Phase 1
1999-09-01
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy in treating
patients who have advanced non-small cell lung cancer.
Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
Completed
Memorial Sloan Kettering Cancer Center
Phase 1
1999-09-01
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy in treating
patients who have advanced non-small cell lung cancer.
ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer
Unknown status
AstraZeneca
Phase 3
2000-05-01
RATIONALE: Some tumors need growth factors produced by the body's white blood cells to keep
growing. ZD 1839 may interfere with the growth factor and stop the tumor from growing. Drugs
used in chemotherapy use different ways to stop tumor cells from dividing so they stop
growing or die. It is not yet known whether chemotherapy is more effective with or without ZD
1839 for non-small cell lung cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy
with or without ZD 1839 in treating patients who have stage IIIB or stage IV non-small cell
lung cancer.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
